Most Recent

image: 23andMe, Genentech Partner on Parkinson’s

23andMe, Genentech Partner on Parkinson’s

By | January 7, 2015

Firms enter a multi-year deal for the analysis of whole-genome sequence data, with an eye toward drug discovery for Parkinson’s disease.

0 Comments

image: Custom Creatures?

Custom Creatures?

By | January 6, 2015

San Francisco-based biotech wants to see its technology applied for inventing new organisms.

0 Comments

image: Doris Bachtrog: Sex Chromosome Wrangler

Doris Bachtrog: Sex Chromosome Wrangler

By | January 1, 2015

Associate Professor, Department of Integrative Biology, University of California, Berkeley. Age: 39

0 Comments

image: Fertility Treatment Fallout

Fertility Treatment Fallout

By | January 1, 2015

Mouse offspring conceived by in vitro fertilization are metabolically different from naturally conceived mice.

8 Comments

image: Picturing Infection

Picturing Infection

By | January 1, 2015

Whole-animal, light-based imaging of infected small mammals

4 Comments

image: Straighten Out

Straighten Out

By | January 1, 2015

Forces from bidirectional growth plates mechanically realign broken bones in infant mice.

0 Comments

image: Stress Fractures

Stress Fractures

By | January 1, 2015

Social adversity shapes humans’ immune systems—and probably their susceptibility to disease—by altering the expression of large groups of genes.

6 Comments

image: Mistaken Identities

Mistaken Identities

By | January 1, 2015

Researchers are working to automate the arduous task of identifying—and amending—mislabeled sequences in genetic databases.

1 Comment

image: Molecular Hub of Autism?

Molecular Hub of Autism?

By | December 30, 2014

Researchers identify a network that includes many genes previously linked to autism spectrum disorders.

0 Comments

image: The Year in Pathogens

The Year in Pathogens

By | December 29, 2014

Ebola, MERS, and enterovirus D68; polio eradication efforts; new regulations on potentially dangerous research

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech